used a PLGMWSR‐OH linker to design CXCR4‐targeted iron oxide nanoparticles (IONPs) which could be activated by MMP‐9 and self‐assembled to give a T2 signal enhancement by about 160% in U87.CD4.CXCR4 tumor.[57]. This evidence concerns the gene MMP9 and neoplasm.